Advanced in Penis Agenesis

Jacques J. Beltrand

Paris, FR 
Advanced in Penis Agenesis
Paris, FR 
OverviewLocationsClinical Research

Overview

Jacques Beltrand practices in Paris, France. Mr. Beltrand is rated as an Advanced expert by MediFind in the treatment of Penis Agenesis. His top areas of expertise are Craniopharyngioma, Type 1 Diabetes (T1D), Low Blood Sugar, Penis Agenesis, and Hormone Replacement Therapy (HRT).

His clinical research consists of co-authoring 82 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Penis Agenesis.

Gender
Male

Locations

Paris, 10116, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Multi-center, Randomized, Parallel, Adaptive, Controlled Trial in Adult and Pediatric Patients With Type 1 Diabetes Using Hybrid Closed Loop System and Control (CSII, MDI and SAP) at Home
Multi-center, Randomized, Parallel, Adaptive, Controlled Trial in Adult and Pediatric Patients With Type 1 Diabetes Using Hybrid Closed Loop System and Control (CSII, MDI and SAP) at Home
Enrollment Status: Completed
Publish Date: August 19, 2025
Intervention Type: Device
Study Phase: Not Applicable
A Prospective, Randomized, Double-Blind Comparison of LY900014 to Humalog With an Open-Label Postprandial LY900014 Treatment Group in Children and Adolescents With Type 1 Diabetes
A Prospective, Randomized, Double-Blind Comparison of LY900014 to Humalog With an Open-Label Postprandial LY900014 Treatment Group in Children and Adolescents With Type 1 Diabetes
Enrollment Status: Completed
Publish Date: January 24, 2022
Intervention Type: Drug
Study Drugs: LY900014, Insulin Lispro
Study Phase: Phase 3
Safety Assessment of DBLUS System in Adolescent and Adult Patients With Type 1 Diabetes and Assessment of Its Clinical Efficacy in a Randomized Trial for 3 Months Followed by an Extension Period
Safety Assessment of DBLUS System in Adolescent and Adult Patients With Type 1 Diabetes and Assessment of Its Clinical Efficacy in a Randomized Trial for 3 Months Followed by an Extension Period
Enrollment Status: Terminated
Publish Date: April 08, 2021
Intervention Type: Device
Study Phase: Not Applicable
An Open-label, Three-center, Randomized, Two-session, Crossover Study, to Assess 4 Days Inpatient, and 6-week Follow-up Home Study Phase Under Remote Monitoring at Only French Centers, the Efficacy and the Safety of the Diabeloop Closed-loop Glucose Control Compared With Sensor-augmented Pump Therapy, in Young Children With Type 1 Diabetes.
An Open-label, Three-center, Randomized, Two-session, Crossover Study, to Assess 4 Days Inpatient, and 6-week Follow-up Home Study Phase Under Remote Monitoring at Only French Centers, the Efficacy and the Safety of the Diabeloop Closed-loop Glucose Control Compared With Sensor-augmented Pump Therapy, in Young Children With Type 1 Diabetes.
Enrollment Status: Completed
Publish Date: March 06, 2020
Intervention Type: Device, Other
Study Phase: Not Applicable
View 3 Less Clinical Trials

82 Total Publications

Real-World Use of Hybrid Closed-Loop System in Very Young Children with Type 1 Diabetes: Daily Glycemic Patterns Support Glycemic Improvements and Highlight Emerging Challenges for Hypoglycemia.
Real-World Use of Hybrid Closed-Loop System in Very Young Children with Type 1 Diabetes: Daily Glycemic Patterns Support Glycemic Improvements and Highlight Emerging Challenges for Hypoglycemia.
Journal: Diabetes technology & therapeutics
Published: November 07, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Beltrand's expertise for a condition
ConditionClose
      View All 47 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile